Éric Dannaoui

14.3k citations

173 papers · 7.4k indexed · 2 hit papers · h-index 47

Impact in

Infectious Diseases top 0.1%
- Antifungal resistance and susceptibility
Microbiology top 0.5%

Papers in

Infectious Diseases 153
- Antifungal resistance and susceptibility 145
Small Animals 53
- Infectious Diseases and Mycology 48

Co-authors: Françoise Dromer Olivier Lortholary Patrick Schwarz Fanny Lanternier Jacques F. Meis Paul E. Verweij Dea Garcia‐Hermoso Stéphane Bretagne
Journals: Antimicrobial Agents and Chemotherapy (28 papers)Journal of Fungi (15 papers)Journal of Clinical Microbiology (12 papers)Clinical Microbiology and Infection (11 papers)Mycoses (9 papers)
Partner nations: France Netherlands Germany

In The Last Decade

Éric Dannaoui

167 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007) 2012 · 384 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Clinical Infectious Diseases
2008 Clinical Microbiology and Infection

Peers

Countries citing papers authored by Éric Dannaoui

Since Specialization

Citations

This map shows the geographic impact of Éric Dannaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Dannaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Dannaoui more than expected).

Fields of papers citing papers by Éric Dannaoui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Dannaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Dannaoui. The network helps show where Éric Dannaoui may publish in the future.

Co-authors

The 25 scholars most cited alongside Éric Dannaoui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Éric Dannaoui Line = papers co-authored together Éric Dannaoui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antagonistic in vitro interaction between olorofim and voriconazole against Aspergillus fumigatus Journal of Antimicrobial Chemotherapy ·勝郎相良, Anne-Laure Bidaud, M.T Monchietti De Maidana, Patrick Schwarz, Marie‐Elisabeth Bougnoux, Éric Dannaoui	2025	0
2	Trichophyton indotineae, from epidemiology to therapeutic Journal de Mycologie Médicale ·Arnaud Jabet, Anne‐Cécile Normand, Sophie Brun, Éric Dannaoui, Claude Bachmeyer, Renaud Piarroux, Christophe Hennequin, Alicia Moreno‐Sabater	2023	52
3	Comparison of the New VITEK MS PRIME System with the Matrix-Assisted Laser Desorption Ionization Biotyper Microflex LT for the Identification of Microorganisms Annals of Laboratory Medicine ·Patrick Grohs, S Wizarat, Suzaiki Ali, Chidiebere Somadina Ike, علی صدقیانی فر, Éric Dannaoui, Isabelle Podglajen	2023	6
4	Disseminated Cryptococcosis Following Eculizumab Therapy: Insight Into Pathogenesis Open Forum Infectious Diseases ·Olivier Lortholary, José Mafokozi, Guangde Qiao, Sarah Sze Wah Wong, Éric Dannaoui, Véronique Frémeaux‐Bacchi, Vishukumar Aimanianda	2023	6
5	Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species Journal de Mycologie Médicale ·Hamed Fakhim, Hamid Badali, Éric Dannaoui, Maryam Nasirian, Emilio Andrés Conforme Parrales, Jérôme fl. 1579-1635 impresor Verdussen, G. P. Zarayskiy, Kazem Ahmadikia, Afsane Vaezi	2022	35
6	In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species Frontiers in Cellular and Infection Microbiology ·Patrick Schwarz, C. Wang, Anne-Laure Bidaud, Frank Sommer, Gert Bange, Éric Dannaoui	2022	5
7	Candida albicans and Candida dubliniensis Show Different Trailing Effect Patterns When Exposed to Echinocandins and Azoles Frontiers in Microbiology ·Olufemi Aremu Fakolade, Emilie Sitterlé, Christophe d’Enfert, Éric Dannaoui, Marie‐Elisabeth Bougnoux	2020	10
8	In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates Journal of Global Antimicrobial Resistance ·Ali Ahmadi, Shahram Mahmoudi, Sassan Rezaie, Toni S. Carter, Éric Dannaoui, Hamid Badali, G. Mathiae, Farzad Aala, Alireza Izadi, Kim Dalla-Bona, Jacques F. Meis, Sadegh Khodavaisy	2019	3
9	Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex Clinical Microbiology and Infection ·Gisele Beatriz Teles Góes, Jean‐Pierre Gangneux, Sophie Cassaing, Laurence Delhaès, Arnaud Fekkar, Damien Dupont, Françoise Botterel, Damien Costa, Nadège Bourgeois‐Nicolaos, Bernard Bouteille, Sandrine Houzé, Éric Dannaoui, Hélène Guegan, Éléna Charpentier, Florence Persat, Loïc Favennec, Laurence Lachaud, Milène Sasso	2019	24
10	Prospective evaluation of azole resistance inAspergillus fumigatusclinical isolates in France: Table 1. Medical Mycology ·Sutha Ganesha Chandran, Françoise Botterel, Emilie Sitterlé, L.Dusart, F. Foulet, Jacques Guillot, José Manuel Correia da Costa, Audra Vaughters, Éric Dannaoui	2015	33
11	Molecular identification of fungi found on decomposed human bodies in forensic autopsy cases International Journal of Legal Medicine ·Patrick Schwarz, Éric Dannaoui, Axel Gehl, 任太花, Christoph G. Birngruber, R. Dettmeyer, Marcel A. Verhoff	2014	19
12	Healthcare-Associated Mucormycosis Clinical Infectious Diseases ·Blandine Rammaert, Fanny Lanternier, Jean‐Ralph Zahar, Éric Dannaoui, Marie‐Elisabeth Bougnoux, Marc Lecuit, Olivier Lortholary	2012	202
13	Candida spp. with Acquired Echinocandin Resistance, France, 2004–20101 Emerging infectious diseases ·Éric Dannaoui, Marie Desnos‐Ollivier, Dea Garcia‐Hermoso, Frédéric Grenouillet, Sophie Cassaing, Marie-Thérèse Baixench, Stéphane Bretagne, Françoise Dromer, Olivier Lortholary, (unknown)	2012	104
14	Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales Journal of Clinical Microbiology ·Roxana G. Vitale, Sybren de Hoog, Patrick Schwarz, Éric Dannaoui, Shuwen Deng, M. Machouart, Kerstin Voigt, Wendy W. J. van de Sande, Somayeh Dolatabadi, Jacques F. Meis, Grit Walther	2011	125
15	Molecular Detection and Identification of Zygomycetes Species from Paraffin-Embedded Tissues in a Murine Model of Disseminated Zygomycosis: a Collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) Evaluation Journal of Clinical Microbiology ·Éric Dannaoui, Patrick Schwarz, Michal Slaný, Juergen Loeffler, Anne Jorde, Manuel Cuenca‐Estrella, Philippe M. Hauser, Silvia Mitidieri, Michel Huerre, Tomáš Freiberger, Peter Gaustad, Felisa L. Sanico, Jacques Billé, David W. Denning, Stéphane Bretagne, Olivier Lortholary	2010	81
16	The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) EUCAST Technical Note on fluconazole. Clinical Microbiology and Infection ·epsilon-collaboration, В.В. Кузьков, P. Vanheuverzwijn, S. Arıkan, Francesco Barchiesi, J. Bille, Erja Chryssanthou, M. Cuenca‐Estrella, Éric Dannaoui, David W. Denning, W. Fegeler, Peter Gaustad, Н Н Климко, Cornelia Lass‐Flörl, Cecil P. Moore, Malcolm Richardson, A. Schmalreck, Jørgen Stenderup, Aristea Velegraki, Paul E. Verweij	2009	12
17	Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clinical Microbiology and Infection ·Jin Lai, В.В. Кузьков, P. Vanheuverzwijn, S. Arıkan, Francesco Barchiesi, J. Bille, Erja Chryssanthou, M. Cuenca‐Estrella, Éric Dannaoui, David W. Denning, W. Fegeler, Peter Gaustad, Cornelia Lass‐Flörl, Cecil P. Moore, Malcolm Richardson, A. Schmalreck, Aristea Velegraki, Paul E. Verweij	2009	111
18	Sequence-Based Identification of Aspergillus, Fusarium , and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here? Journal of Clinical Microbiology ·S. Arunmozhi Balajee, Andrew M. Borman, Mary E. Brandt, J. Cano, M. Cuenca‐Estrella, Éric Dannaoui, Josep Guarro, Gerhard Haase, Christopher C. Kibbler, Wieland Meyer, Kerry O’Donnell, C. A. Petti, J. L. Rodriguez-Tudela, Deanna A. Sutton, Aristea Velegraki, Brian L. Wickes	2008	257
19	EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts Clinical Microbiology and Infection ·J. L. Rodríguez-Tudela, Maiken Cavling Arendrup, Francesco Barchiesi, Jacques Billé, Erja Chryssanthou, M. Cuenca‐Estrella, Éric Dannaoui, David W. Denning, J. Peter Donnelly, Françoise Dromer, W. Fegeler, Cornelia Lass‐Flörl, Caroline M. Moore, Malcolm Richardson, Per Sandven, Aristea Velegraki, Paul E. Verweij Hit paper breakdown →	2008	549
20	Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) Clinical Microbiology and Infection ·Manuel Cuenca‐Estrella, Maiken Cavling Arendrup, Erja Chryssanthou, Éric Dannaoui, Cornelia Lass‐Flörl, Per Sandven, Aristea Velegraki, J. L. Rodríguez-Tudela	2007	44

About Éric Dannaoui

Éric Dannaoui is a scholar working on Infectious Diseases, Small Animals, Microbiology, Epidemiology and Cell Biology, having authored 173 papers that have together received 7.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (145 papers), Fungal Infections and Studies (95 papers), Infectious Diseases and Mycology (48 papers), Plant Pathogens and Fungal Diseases (28 papers), Nail Diseases and Treatments (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (17 papers), Mycotoxins in Agriculture and Food (12 papers) and Fungal Biology and Applications (12 papers). The work is most often cited by research in Infectious Diseases (5.8k citations), Microbiology (109 citations), Epidemiology (4.8k citations), Small Animals (1000 citations) and Cell Biology (1.2k citations). Éric Dannaoui has collaborated with scholars based in France, Netherlands and Germany. Frequent co-authors include Françoise Dromer, Olivier Lortholary, Patrick Schwarz, Fanny Lanternier, Jacques F. Meis, Paul E. Verweij, Dea Garcia‐Hermoso, Stéphane Bretagne, Françoise Botterel and Anuradha Chowdhary. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Fungi, Journal of Clinical Microbiology, Clinical Microbiology and Infection and Mycoses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact